DioGenix Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 5
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $11M
Latest Deal Amount

DioGenix General Information


Developer of molecular diagnostics. The company is a molecular diagnostics enterprise focused on the development and commercialization of novel, non-invasive diagnostic, prognostic and treatment response monitoring tests.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • 3 Bethesda Metro Center
  • Suite 700
  • Bethesda, MD 20814
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DioGenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Jan-2015 $11M 0000 0000 Completed Clinical Trials - General
3. Later Stage VC (Series B) 05-Dec-2013 00.00 0000 Completed Startup
2. Early Stage VC (Series B) 18-Dec-2012 $1.5M $6.75M Completed Startup
1. Early Stage VC (Series A) 28-Apr-2009 $5.25M $5.25M 00.00 Completed Startup
To view DioGenix’s complete valuation and funding history, request access »

DioGenix Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view DioGenix’s complete cap table history, request access »

DioGenix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DioGenix Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nerveda Venture Capital Majority 000 0000 000000 0
To view DioGenix’s complete investors history, request access »